3BBLACKBIO

3B Blackbio Dx Limited

3B Blackbio Dx Limited (3BBLACKBIO) financial statements and selected valuation metrics through 30 June 2026.

Healthcare›Healthcare›Healthcare Services›Healthcare Service Provider

kilpest.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹1446.40
Market cap
1,239 Cr
Stock P/E
22.3
P/B
3.82
Dividend yield
0.3%
ROE (FY26)
17.7%
ROCE (FY26)
23.1%
Operating margin (FY26)
36.4%
Debt / equity (FY26)
0.0096
OCF / EBITDA (FY26)
92.4%
OCF / EBITDA (3Y)
87.8%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

3BBLACKBIO is classified under the Healthcare Service Provider industry in the platform's taxonomy (reporting type: industrial).

Company snapshot

8thBy market cap

Ranked among 10 companies in Healthcare Service Provider.

What we see

Positives
  • ✓Net margin of 42.2% — the business keeps a healthy share of every rupee it earns.
3 more signals from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales19 Cr18 Cr23 Cr19 Cr29 Cr25 Cr22 Cr22 Cr34 Cr50 Cr35 Cr33 Cr
Operating expenses (approx.)11 Cr9 Cr13 Cr8 Cr13 Cr10 Cr15 Cr10 Cr19 Cr29 Cr27 Cr25 Cr
EBITDA8 Cr9 Cr10 Cr11 Cr16 Cr15 Cr8 Cr12 Cr15 Cr22 Cr8 Cr9 Cr
OPM %40.6%50.2%43.0%56.3%55.5%59.4%35.2%53.2%43.5%43.1%24.0%25.4%
Other income3 Cr3 Cr4 Cr4 Cr3 Cr3 Cr5 Cr4 Cr6 Cr6 Cr10 Cr6 Cr
Interest0.04 Cr0.03 Cr0.04 Cr0.0062 Cr0.03 Cr0.02 Cr0.04 Cr0.01 Cr0.04 Cr0.09 Cr0.10 Cr0.10 Cr
Depreciation0.24 Cr0.32 Cr0.30 Cr0.27 Cr0.27 Cr0.27 Cr0.28 Cr0.28 Cr0.58 Cr0.38 Cr4 Cr1 Cr
Profit before tax10 Cr11 Cr14 Cr14 Cr19 Cr18 Cr13 Cr16 Cr20 Cr27 Cr15 Cr13 Cr
Tax %26.0%23.6%36.0%21.3%23.0%24.2%35.9%20.3%23.4%16.4%33.1%32.1%
Net profit8 Cr9 Cr9 Cr11 Cr15 Cr13 Cr8 Cr13 Cr15 Cr22 Cr10 Cr9 Cr
EPS (₹)₹8.86₹9.94₹10.26₹13.19₹17.35₹15.75₹9.38₹14.76₹17.55₹26.19₹11.44₹10.48

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales17 Cr23 Cr23 Cr29 Cr227 Cr81 Cr62 Cr74 Cr96 Cr142 CrSign in free for the trailing twelve months
Operating expenses (approx.)15 Cr18 Cr16 Cr20 Cr77 Cr44 Cr33 Cr41 Cr46 Cr85 CrSign in free for the trailing twelve months
EBITDA3 Cr5 Cr7 Cr9 Cr150 Cr37 Cr29 Cr33 Cr50 Cr57 CrSign in free for the trailing twelve months
OPM %14.8%23.2%31.0%32.3%66.1%46.0%47.1%44.5%51.9%40.0%Sign in free for the trailing twelve months
Other income0.27 Cr0.28 Cr0.74 Cr2 Cr3 Cr7 Cr7 Cr13 Cr15 Cr26 CrSign in free for the trailing twelve months
Interest0.98 Cr0.73 Cr0.46 Cr0.33 Cr0.23 Cr0.11 Cr0.20 Cr0.12 Cr0.11 Cr0.24 CrSign in free for the trailing twelve months
Depreciation0.45 Cr0.46 Cr0.55 Cr0.54 Cr0.62 Cr0.67 Cr0.86 Cr1 Cr1 Cr5 CrSign in free for the trailing twelve months
Profit before tax1 Cr5 Cr7 Cr10 Cr152 Cr43 Cr35 Cr44 Cr64 Cr77 CrSign in free for the trailing twelve months
Tax %19.0%24.1%24.6%23.5%25.1%25.5%26.5%27.6%25.5%22.1%Sign in free for the trailing twelve months
Net profit1 Cr3 Cr5 Cr8 Cr114 Cr32 Cr26 Cr32 Cr48 Cr60 CrSign in free for the trailing twelve months
EPS (₹)——₹8.18₹10.22₹151.68₹42.89₹34.55₹37.46₹55.66₹69.94Sign in free for the trailing twelve months
Dividend payout %————0.0%48.0%17.1%6.8%5.4%5.7%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital6 Cr6 Cr6 Cr7 Cr7 Cr7 Cr7 Cr9 Cr9 Cr9 Cr
Reserves5 Cr12 Cr16 Cr25 Cr125 Cr146 Cr164 Cr214 Cr260 Cr316 Cr
Borrowings9 Cr6 Cr6 Cr4 Cr2 Cr3 Cr2 Cr0.85 Cr0.31 Cr3 Cr
Other liabilities6 Cr6 Cr7 Cr7 Cr43 Cr17 Cr16 Cr22 Cr24 Cr43 Cr
Total liabilities26 Cr30 Cr36 Cr45 Cr194 Cr192 Cr214 Cr248 Cr296 Cr378 Cr
Fixed assets (net)3 Cr3 Cr4 Cr4 Cr5 Cr7 Cr8 Cr7 Cr7 Cr28 Cr
CWIP0.05 Cr0.15 Cr0.10 Cr0.20 Cr0.13 Cr0.11 Cr0.09 Cr———
Investments0 Cr0 Cr1 Cr1 Cr70 Cr104 Cr92 Cr117 Cr156 Cr158 Cr
Loans & advances——0.05 Cr0.06 Cr0.10 Cr0.08 Cr0.09 Cr0 Cr0 Cr0 Cr
Inventories4 Cr4 Cr5 Cr4 Cr5 Cr7 Cr8 Cr8 Cr9 Cr18 Cr
Trade receivables14 Cr16 Cr18 Cr20 Cr35 Cr30 Cr34 Cr36 Cr37 Cr50 Cr
Cash & bank0.43 Cr1 Cr2 Cr9 Cr2 Cr3 Cr6 Cr14 Cr12 Cr38 Cr
Other assets4 Cr5 Cr6 Cr7 Cr77 Cr41 Cr66 Cr65 Cr74 Cr86 Cr
Total assets26 Cr30 Cr36 Cr45 Cr194 Cr192 Cr214 Cr248 Cr296 Cr378 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity——4 Cr7 Cr98 Cr37 Cr23 Cr27 Cr43 Cr52 Cr
Cash from investing——-0.69 Cr-0.64 Cr-70 Cr-28 Cr12 Cr-20 Cr-34 Cr-24 Cr
Cash from financing——-1 Cr0.81 Cr-2 Cr-15 Cr-5 Cr-4 Cr-3 Cr-0.52 Cr
Net cash flow——2 Cr7 Cr26 Cr-6 Cr30 Cr3 Cr7 Cr32 Cr
Free cash flow (OCF − Capex)——3 Cr—98 Cr35 Cr23 Cr27 Cr42 Cr27 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %11.9%21.6%25.6%27.5%101.3%24.8%17.9%19.6%23.6%23.1%
ROE %10.1%18.5%22.1%19.9%67.3%16.4%11.6%14.5%17.6%17.7%
Debtor days29825628925256135200178138128
Inventory days1691091621123588163155122187
Days payable18010412793214268732871
Cash conversion cycle28726232427170181294261233245
OCF / EBITDA %——49.4%75.6%65.0%100.6%78.6%81.7%86.5%92.4%
OCF / EBITDA % (3 years)————64.9%72.2%73.0%87.9%83.1%87.8%
Debt / equity0.780.320.280.110.020.020.010.00380.00110.0096
Current ratio2.053.033.084.822.764.828.057.047.115.27
Net debt / EBITDA3.220.830.59-0.600.0001-0.02-0.14-0.39-0.24-0.62